»ª¹¤¿Æ¼¼Óë¹ú»ú¼¯ÍÅ»úеÍýÏëÑо¿ÔºÇ©ÊðÕ½ÂÔÏàÖúЭÒé һĶÌïÄÉ˹´ï¿ËÉÏÊÐÊ×ÈÕ±©µø31.7% ũҵµçÉ̵ÚÒ»¹ÉÃæÁÙÓ¯ÀûÄ¥Á· ¹ú²úÊ×̨Ì×45Íò¶Ö/Äê¾Û±ûÏ©ÔìÁ£»ú×é³ö³§ ÖØ°õ | TEÌ©¿Æµç×ÓÓ벩ÍþºÏ½ðµÈ¿çȦÁªºÏ £¬Í»ÆÆÆû³µ¡°ÂÁ´úÍ­¡±ÊÖÒÕħÖä °Âº£AohiÐǽ¢ÄÜÁ¿²Õ³äµç±¦360Ôª¿ÉÈëÊÖ Dayforce³ÉΪÕÇ·ù×î´óµÄ±êÆÕ500³É·Ý¹É Ӣΰ´ïÔÒÏÂ15ÒÚÃÀÔª £¬´ÓLambda×âÓôîÔØ×Ô¼ÒоƬµÄGPUЧÀÍÆ÷ ÍòÔ£¿Æ¼¼¿¯ÐÐÔ¼377.49Íò¹É´úÏ¢¹É·Ý ½»Í¨ÒøÐÐÁÁÏàµÚÆß½ìÖа¢Õ¹ÀÀ»á ¶àµØÐû²¼ÍøÔ¼³µÐÐҵΣº¦ÌáÐÑ ÌØÀÊÆÕ³ÆÑÇÃÀÄáÑÇÓë°¢Èû°Ý½®½«ÓÚÖÜÎåÇ©ÊðÇ徲ЭÒé MSCIÖ¸Êýµ÷½â Öйú×ʲú»òÓ­ÔöÁ¿×ʽð Á½¼ÒÉÏÊÐÒøÐÐ £¬Í³Ò»Ìì±»µÚÈý´Î¾ÙÅÆ£¡ ¡°¹ûÁ´Èý¾ÞÍ·¡±¿ñ±¼ £¬°ëÄ걩׬³¬90ÒÚ Í»·¢£¡µÂÇÚ±»¹ûÕæÑµ³â £¬·£¿î191.2Íò Òµ¼¨¿÷Ëð¹É¼ÛÈ´·­±¶£º¹ãÉúÌõÄͶ×ÊÈËÕæµÄÖªµÀ×Ô¼ºÔÚ³´Ê²Ã´Â𣿠¡°ÆÆ±ù¡±¼¸ºÎ£¿ÃÀ¶í»áÎîµÄ¿ÉÄÜÓ°Ïì ½Ü´´ÖÇÄÜ£º¹«Ë¾½«ÔöÇ¿ÓëͶ×ÊÕߵĻ¥¶¯Óë½»Á÷ A¹ÉäºÐ¾­¼Ã¶ÌÏß×߸ß £¬½ðÔ˼¤¹âÕdz¬3% ÏûºÄµç×ÓÐÐÒµÉÏÊй«Ë¾²ÆÎñ×ܼàPK£ºÉî¿Æ¼¼ÄªÉÐÔÆÄêËê×î´ó £¬59Ëê £¬2004Äê10ÔÂ×îÏÈÈÎÖ° ÃÀ¹ú8Ô¡°Ð¡·ÇÅ©¡±Êý¾Ýȱ·¦Ô¤ÆÚ £¬ÃÀÁª´¢9Ô½µÏ¢¸ÅÂʳ¬99% ÆÊÎö»¯Ñ§¼Ò¡¢Öйú¿ÆÑ§ÔºÔºÊ¿Ò¦ÊØ×¾ÊÅÊÀ £¬ÏíÄê90Ëê º£¹¤×°±¸¿´·¨Õðµ´·´µ¯ £¬Öг¬¿Ø¹É¡¢ÉϺ£»¦¹¤Ë«Ë«ÕÇÍ£ ±ÈÑǵÏÓ¡¶ÈÏúÁ¿Á¢Òì¸ß Óлù½ð˾ÀíʵÅÌ׬ÁËÒ»°Ù¶àÍò£¡ µãÆÀƽ°²°ëÄ걨£ºÁ¢ÒìÆÆ¾Ö £¬ÈÍÐв»µ¡ ÔçÅÌ£ºÃÀ¹É¼ÌÐøÉÏÑï ±êÆÕ500Ö¸Êý´´ÅÌÖÐ¸ß ¸ÒÏûºÄ £¬ÄÜÏûºÄ £¬Ô¸ÏûºÄ£¡¹ú¼Ò·¢¸ÄίÐû²¼À©ÏûºÄ²½·¥ ÄÁÔ­¹É·ÝÄ⿯Ðв»Áè¼Ý50ÒÚÔª¹«Ë¾Õ®È¯»ñ×¢²áÅú¸´ µçÍø×°±¸ÐÐÒµ¶­ÃØÐ½³ê°ñ£º°²¿ÆÈðÊÕÀûË«½µ ¶­ÃØÂÞÒ¶À¼ÄêнÕÇÖÁ193Íòλ¾ÓÒµÄÚǰÈý ¼ªÐÇÐÂÄÜÔ´ÄâÕÛÈÃÔ¼5.71%¿¯ÐÐ1289.125Íò¹É ¾»³ïÔ¼73.2Íò¼ÓÔª °Ù¼ÃÉñÖݸ۹ɹ«Ë¾Éî¶ÈÑо¿£ºÁúÍ·Biopharma¸ß̧¸ß´ò £¬ ÉÌÒµ»¯ºÍÑз¢Ó­ÊÕ»ñÆÚ ÉîÒ¹Òý±¬ £¬ÃÀÁª´¢´óÐÂÎÅ£¡¸Û¹ÉͨÁ¢ÒìÒ©ETF£¨520880£©·ÅÁ¿Õdz¬4% £¬ÐÅ´ïÉúÎï¡¢°Ù¼ÃÉñÖݼ¨ºóÃ͹¥ ÖйúÁªÍ¨Ò»Á¬Ê®ÆßÄêÈëÑ¡²Æ²úÌìÏÂ500Ç¿°ñµ¥ ÂÀ¾üÓëÖйúÌú½¨¶­Ê³¤´÷ºÍ¸ù̸ÅÐ ÑëÐÐÔ¤¸æ7000ÒÚÔªÂò¶ÏÊ½Äæ»Ø¹º²Ù×÷ £¬»ú¹¹½â¶Á ÆæÈðÆû³µÍ¨¹ý¸Û¹ÉñöѶ ¹ÀֱֵָǧÒÚ ÌÚѶ¿Ø¹ÉÒò¹º¹ÉȨ»ñÐÐʹ¿¯ÐÐ40.16Íò¹É »¥ÁªÍø½ðÈÚ°å¿éÕðµ´×ßÇ¿ £¬Í¬»¨Ë³Õdz¬5% Ӣΰ´ï¼Ó³Ö£¡ÔÆÐ§ÀÍÉÌLambda³å´ÌIPOǰÈÚ×Ê ¹ÀÖµ»òÆÆ40ÒÚÃÀÔª º£µ×À̰ëÄ걨ÏÔʾÍâÂôÓªÒµÓªÊÕͬ±ÈÔöÌí½ü60% ÑÇÂíÑ·¹¥»÷Prime»áÔ±Ãâ·ÑÅäË͹²ÏíÐÐΪ Í¬ÒæÖУº»úеÈËëìÉþÒÑÓÐС¹æÄ£ÏúÊÛ¶©µ¥ ÖØ²Ö¹ÉÃûµ¥¸¡ÏÖ ¶à¼ÒÉÏÊй«Ë¾¶þ¼¾¶È»ñȯÉÌÔö³Ö ÌØË¹À­ÇëÇó·¨Ôº×÷·Ï2.43ÒÚÃÀÔªµÄÅãÉóÍŲþö ¾©¶«ÅÌǰϵø0.6% ½ÓÁ¬½µ¼Ûºó ½ð°²¹ú¼ÍÖÕÅ×ÊÛ¿÷Ëð×ʲú »ÕÉÌÒøÐж­Ê³¤ £¬¡°´ó¿ç¶È¡±ÂÄРȫÎÄ|¿ìÊÖQ2Òµ¼¨»áʵ¼£ºÔ¤¼Æ½ñÄê¿ÉÁéAIÏà¹Ø×Ê±ÊÆ§³ö½ÏÄêÍ·Ô¤Ëã·­·¬ ÏÂÖÜ25¹ÉÃæÁÙ½â½û ºÏ¼Æ½â½ûÊÐÖµ795.29ÒÚÔª